Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years
- PMID: 2874863
- PMCID: PMC1341237
- DOI: 10.1136/bmj.293.6544.420
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years
Abstract
Sulphasalazine is being used increasingly to treat rheumatoid arthritis, though its long term safety profile has not been established in this condition. The incidence and nature of adverse effects occurring in 774 patients with rheumatoid arthritis treated with sulphasalazine for periods ranging from one to 11 years were therefore noted. Altogether 205 of the patients stopped treatment permanently due to an adverse effect. One hundred and fifty six (76%) of these events occurred within three months and few beyond the first year. Most events were trivial and were self limiting after withdrawal of the drug; of the potentially more serious adverse effects, 33 (66%) occurred within three months of treatment. None of the patients died or suffered lasting ill effects. It is concluded that adverse effects of treatment with sulphasalazine are generally seen within three months; though regular monitoring is desirable during that period, thereafter few worrying problems occur.
Similar articles
-
Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.Br J Rheumatol. 1988 Dec;27(6):465-8. doi: 10.1093/rheumatology/27.6.465. Br J Rheumatol. 1988. PMID: 2904830
-
Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.Scand J Rheumatol. 1993;22(5):229-32. doi: 10.3109/03009749309095128. Scand J Rheumatol. 1993. PMID: 7901898
-
Adverse reactions to sulfasalazine: the British experience.J Rheumatol Suppl. 1988 Sep;16:17-21. J Rheumatol Suppl. 1988. PMID: 2903924 Review.
-
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1102-4. doi: 10.1136/bmj.287.6399.1102. Br Med J (Clin Res Ed). 1983. PMID: 6138117 Free PMC article. Clinical Trial.
-
[Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].Clin Ter. 1997 Jan-Feb;148(1-2):7-13. Clin Ter. 1997. PMID: 9377840 Review. Italian.
Cited by
-
Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.BMC Gastroenterol. 2001;1:8. doi: 10.1186/1471-230x-1-8. Epub 2001 Aug 29. BMC Gastroenterol. 2001. PMID: 11570976 Free PMC article.
-
Hepatobiliary manifestations of inflammatory bowel disease in children.Clin Exp Hepatol. 2019 Sep;5(3):203-209. doi: 10.5114/ceh.2019.87632. Epub 2019 Sep 5. Clin Exp Hepatol. 2019. PMID: 31598556 Free PMC article. Review.
-
An unusual cause for collapse in a patient with arthritis.Intensive Care Med. 1996 Oct;22(10):1096-7. doi: 10.1007/BF01699235. Intensive Care Med. 1996. PMID: 8923077
-
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.Ann Rheum Dis. 1996 May;55(5):328-30. doi: 10.1136/ard.55.5.328. Ann Rheum Dis. 1996. PMID: 8660109 Free PMC article. Clinical Trial.
-
High fever induced by sulphasalazine.BMJ. 1995 Nov 4;311(7014):1204. doi: 10.1136/bmj.311.7014.1204b. BMJ. 1995. PMID: 7488900 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical